This is a translation of the Swedish press release published 2023-02-14, 08.00 CET
Neola Medical AB (publ) today publishes the Q4 report of 2022 (in Swedish). The report is available at the company’s website and is attached to the press release.
A rights issue was carried out and secured capital for the continued work with clinical and technical studies. An important milestone was achieved when the company obtained certification of the quality management system according to ISO 13485. Article published in Pediatric Research shows the advantages of the technology used in Neola®. The largest clinical study with 100 newborns was finalized and positive subgroup results show that the technology workswell for measuring the lungs of newborn babies. Key recruitments have been made to strengthen both regulatory and clinical competence ahead of the continued work for market approval by the FDA in the USA and CE-mark in Europe.
Read the entire press release (in Swedish) here: Press release (in Swedish)